63 studies found for:    Open Studies | "Parathyroid Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Parathyroid Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas
Condition: Parathyroid Disease
Intervention: Drug: FACBC
2 Unknown  Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders
Conditions: Osteoporosis;   Osteitis Deformans;   Parathyroid Diseases
Intervention:
3 Recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Conditions: Neuroendocrine Neoplasms;   Thyroid Neoplasms;   Parathyroid Neoplasms;   Adrenal Neoplasm;   Neuroblastoma
Intervention:
4 Unknown  Input of C11-Choline PET/CT in Localization of Parathyroid Adenoma
Condition: Hyperparathyroidism
Intervention: Procedure: C11-Choline PET/CT
5 Recruiting EC17 for Intraoperative Imaging for Parathyroidectomy
Condition: Primary Hyperparathyroidism
Intervention: Drug: EC17
6 Recruiting Studies of Elevated Parathyroid Activity
Conditions: Hyperparathyroidism;   Hypocalcemia;   Hypoparathyroidism;   Parathyroid Neoplasm
Intervention:
7 Recruiting Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.
Condition: Secondary Hyperparathyroidism Due to Renal Causes
Interventions: Drug: Paricalcitol;   Drug: Calcifediol
8 Unknown  Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)
Condition: Secondary Hyperparathyroidism
Intervention: Drug: Cinacalcet HCl
9 Unknown  Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary Hyperparathyroidism
Condition: Primary Hyperparathyroidism (PHPT)
Intervention:
10 Recruiting The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma
Conditions: Pleural Neoplasms;   Mesothelioma;   Pneumothorax;   Parathyroid Neoplasms;   Benign Tumor of the Thyroid;   Tumor of the Thyroid
Interventions: Other: Blood sampling;   Other: Control Group
11 Recruiting A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
Condition: Secondary Hyperparathyroidism
Interventions: Drug: ASP7991;   Drug: Cinacalcet;   Drug: Placebo
12 Recruiting To Assess the Long-term Safety of AMG 416 in the Treatment of SHPT in Subjects With CKD on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Intervention: Drug: AMG 416
13 Recruiting Thymus Transplantation Safety-Efficacy
Conditions: Complete DiGeorge Anomaly;   DiGeorge Syndrome;   DiGeorge Anomaly;   Complete DiGeorge Syndrome
Interventions: Biological: Thymus  Tissue for Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Basiliximab;   Drug: Mycophenolate mofetil
14 Recruiting Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients
Conditions: Kidney Failure;   Secondary Hyperparathyroidism;   Vascular Diseases
Intervention: Drug: Cinacalcet
15 Recruiting The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry
Condition: Primary Hyperparathyroidism
Intervention:
16 Unknown  Genetics and Psychopathology in the 22q11 Deletion Syndrome
Condition: Chromosome 22q11.2 Deletion Syndrome
Intervention:
17 Unknown  Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
Condition: Cured Primary Hyperparathyroidism, Concommitant Osteopenia or Osteoporosis
Interventions: Drug: Strontium Ranelate + Ca/Vitamin-D;   Drug: Placebo
18 Unknown  Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)
Conditions: Stage 5 Chronic Kidney Disease (CKD);   Secondary Hyperparathyroidism (SHPT);   Hemodialysis (HD)
Interventions: Drug: Lunacalcipol 180;   Drug: Lunicalcipol 270
19 Not yet recruiting Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy
Conditions: Renal Insufficiency, Chronic;   Renal Osteodystrophy
Interventions: Drug: Yougui granules;   Drug: Zuogui granules;   Drug: Yougui granules placebo;   Drug: Zuogui granules placebo
20 Recruiting Denosumab in Primary Hyperparathyroidism
Condition: Primary Hyperparathyroidism
Interventions: Drug: Denosumab;   Other: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years